Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 916

1.

VISCERAL AND SUBCUTANEOUS FAT INCREASED AFTER TREATMENT OF GRAVES DISEASE.

Ito A, Ando T, Nozaki A, Haraguchi A, Horie I, Kawakami A.

Endocr Pract. 2020 Jan 22. doi: 10.4158/EP-2019-0459. [Epub ahead of print]

PMID:
31968183
2.

HYPOTHYROIDISM COULD BE A POTENTIAL FACTOR TO PROLONG SUBCUTANEOUS NODULES OF EXENATIDE ONCE WEEKLY: A CASE REPORT.

Ito A, Kamata A, Nozaki A, Ando T, Kawakami A.

AACE Clin Case Rep. 2019 Apr 25;5(3):e197-e200. doi: 10.4158/ACCR-2018-0418. eCollection 2019 May-Jun.

3.

Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.

Nakaoka Y, Isobe M, Tanaka Y, Ishii T, Ooka S, Niiro H, Tamura N, Banno S, Yoshifuji H, Sakata Y, Kawakami A, Atsumi T, Furuta S, Kohsaka H, Suzuki K, Hara R, Maejima Y, Tsukamoto H, Takasaki Y, Yamashita K, Okada N, Yamakido S, Takei S, Yokota S, Nishimoto N.

Rheumatology (Oxford). 2020 Jan 17. pii: kez630. doi: 10.1093/rheumatology/kez630. [Epub ahead of print]

PMID:
31951279
4.

A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy.

Nakane S, Mukaino A, Higuchi O, Yasuhiro M, Takamatsu K, Yamakawa M, Watari M, Tawara N, Nakahara KI, Kawakami A, Matsuo H, Ando Y.

J Autoimmun. 2020 Jan 7:102403. doi: 10.1016/j.jaut.2020.102403. [Epub ahead of print]

PMID:
31924415
5.

An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial.

Koga T, Hagimori N, Sato S, Morimoto S, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A.

Medicine (Baltimore). 2020 Jan;99(1):e18328. doi: 10.1097/MD.0000000000018328.

6.

Association between human T cell leukemia virus type-1 (HTLV-1) infection and advanced periodontitis in relation to atherosclerosis among elderly Japanese: a cross-sectional study.

Shimizu Y, Yamanashi H, Kitamura M, Furugen R, Iwasaki T, Fukuda H, Hayashida H, Kawasaki K, Kiyoura K, Kawashiri SY, Saito T, Kawakami A, Maeda T.

Environ Health Prev Med. 2019 Dec 28;24(1):81. doi: 10.1186/s12199-019-0836-2.

7.

Reactive arthritis induced by active extra-articular tuberculosis: A case report.

Endo Y, Kawashiri SY, Koga T, Okamoto M, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Medicine (Baltimore). 2019 Dec;98(49):e18008. doi: 10.1097/MD.0000000000018008.

8.

Hydroxychloroquine inhibits IL-1β production from amyloid-stimulated human neutrophils.

Fujita Y, Matsuoka N, Temmoku J, Furuya MY, Asano T, Sato S, Kobayashi H, Watanabe H, Suzuki E, Urano T, Kozuru H, Yatsuhashi H, Koga T, Kawakami A, Migita K.

Arthritis Res Ther. 2019 Nov 27;21(1):250. doi: 10.1186/s13075-019-2040-6.

9.

Recent findings regarding the effects of microRNAs on fibroblast-like synovial cells in rheumatoid arthritis.

Iwamoto N, Kawakami A.

Immunol Med. 2019 Dec;42(4):156-161. doi: 10.1080/25785826.2019.1695490. Epub 2019 Nov 26.

PMID:
31770498
10.

Gastric mucormycosis complicated by a gastropleural fistula: A case report and review of the literature.

Uchida T, Okamoto M, Fujikawa K, Yoshikawa D, Mizokami A, Mihara T, Kondo A, Ohba K, Kurohama K, Nakashima M, Sekine I, Nakamura S, Miyazaki Y, Kawakami A.

Medicine (Baltimore). 2019 Nov;98(48):e18142. doi: 10.1097/MD.0000000000018142. Review.

11.

Drop Head Syndrome as a Rare Complication in Mixed Connective Tissue Disease: A Case Report.

Akagi M, Umeda M, Hashisako M, Hara K, Tsuji S, Endo Y, Takatani A, Shimizu T, Fukui S, Koga T, Kawashiri SY, Iwamoto N, Igawa T, Ichinose K, Tamai M, Nakamura H, Origuchi T, Niino D, Kawakami A.

Intern Med. 2019 Nov 18. doi: 10.2169/internalmedicine.3626-19. [Epub ahead of print]

12.

Validation of the English version of the difficulty of life scale for patients with ulcerative colitis.

Kawakami A, Choong LM, Tanaka M, Kunisaki R, Maeda S, Bjarnason I, Hayee B.

Eur J Gastroenterol Hepatol. 2019 Nov 7. doi: 10.1097/MEG.0000000000001595. [Epub ahead of print]

PMID:
31714389
13.

Familial Background Factors And Their Association With Non-Organic Visual Loss.

Takahashi M, Kunikata H, Kato K, Kawakami A, Nakazawa T.

Clin Ophthalmol. 2019 Oct 21;13:2059-2061. doi: 10.2147/OPTH.S212365. eCollection 2019.

14.

First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort.

Jinnin M, Ohta A, Ishihara S, Amano H, Atsumi T, Fujimoto M, Kanda T, Kawaguchi Y, Kawakami A, Mimori A, Mimori T, Mimura T, Muro Y, Sano H, Shimizu J, Takeuchi T, Tanaka Y, Yamamoto K, Sumida T, Kohsaka H; Research Team for Autoimmune Diseases, The Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare.

Ann Rheum Dis. 2019 Nov 6. pii: annrheumdis-2019-215488. doi: 10.1136/annrheumdis-2019-215488. [Epub ahead of print]

PMID:
31694813
15.

Diagnostic efficacy of ultrasound detection of enthesitis in peripheral spondyloarthritis.

Fujikawa K, Kawashiri SY, Endo Y, Mizokami A, Tsukada T, Mine M, Uetani M, Kawakami A.

Mod Rheumatol. 2019 Nov 14:1-7. doi: 10.1080/14397595.2019.1687113. [Epub ahead of print]

PMID:
31663417
16.

RENAL FUNCTION AND PLASMA RENIN ACTIVITY AS POTENTIAL FACTORS CAUSING HYPERKALEMIA IN PATIENTS WITH THYROID CARCINOMA UNDERGOING THYROID HORMONE WITHDRAWAL FOR RADIOACTIVE IODINE THERAPY.

Niri T, Horie I, Ando T, Kawahara H, Ueda M, Eto M, Sako A, Ikeuchi Y, Nakao T, Nakashima Y, Shigeno R, Ito A, Nozaki A, Haraguchi A, Natsuda S, Sagara I, Akazawa S, Kamada A, Imaizumi M, Abiru N, Usa T, Kawakami A.

Endocr Pract. 2019 Oct 25. doi: 10.4158/EP-2019-0374. [Epub ahead of print]

PMID:
31652100
17.

Perturbation of the titin/MURF1 signaling complex is associated with hypertrophic cardiomyopathy in a fish model and in human patients.

Higashikuse Y, Mittal N, Arimura T, Yoon SH, Oda M, Enomoto H, Kaneda R, Hattori F, Suzuki T, Kawakami A, Gasch A, Furukawa T, Labeit S, Fukuda K, Kimura A, Makino S.

Dis Model Mech. 2019 Nov 15;12(11). pii: dmm041103. doi: 10.1242/dmm.041103.

18.

Serial analysis of cytokine and chemokine profiles and viral load in severe fever with thrombocytopenia syndrome: Case report and review of literature.

Fujikawa K, Koga T, Honda T, Uchida T, Okamoto M, Endo Y, Mihara T, Kondo A, Shimada S, Hayasaka D, Morita K, Mizokami A, Kawakami A.

Medicine (Baltimore). 2019 Oct;98(42):e17571. doi: 10.1097/MD.0000000000017571. Review.

19.

Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.

Endo Y, Koga T, Umeda M, Furukawa K, Sasaki D, Yanagihara K, Kawakami A.

Rheumatology (Oxford). 2019 Oct 3. pii: kez445. doi: 10.1093/rheumatology/kez445. [Epub ahead of print] No abstract available.

PMID:
31580461
20.

Chlamydia-induced reactive arthritis diagnosed during gout flares: A case report and cumulative effect of inflammatory cytokines on chronic arthritis.

Sumiyoshi R, Koga T, Tsuji S, Endo Y, Takatani A, Shimizu T, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Medicine (Baltimore). 2019 Oct;98(40):e17233. doi: 10.1097/MD.0000000000017233.

21.

Atypical phenotype without fever in a Japanese family with an autosomal dominant transmission of familial Mediterranean fever due to heterozygous MEFV Thr577Asn mutations.

Endo Y, Koga T, Nakashima M, Mishima H, Yoshiura KI, Kawakami A.

Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):161-162. Epub 2019 Sep 23. No abstract available.

22.

Pattern of fin rays along the antero-posterior axis based on their connection to distal radials.

Hamada H, Uemoto T, Tanaka Y, Honda Y, Kitajima K, Umeda T, Kawakami A, Shinya M, Kawakami K, Tamura K, Abe G.

Zoological Lett. 2019 Sep 18;5:30. doi: 10.1186/s40851-019-0145-z. eCollection 2019.

23.

Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial.

Takada K, Katada Y, Ito S, Hayashi T, Kishi J, Itoh K, Yamashita H, Hirakata M, Kawahata K, Kawakami A, Watanabe N, Atsumi T, Takasaki Y, Miyasaka N.

Rheumatology (Oxford). 2019 Sep 20. pii: kez394. doi: 10.1093/rheumatology/kez394. [Epub ahead of print]

PMID:
31539061
24.

Clinical analysis of pre-existing diabetes mellitus and dipeptidyl peptidase-4 inhibitors in patients with remitting seronegative symmetrical synovitis and pitting edema syndrome.

Horai Y, Origuchi T, Iwanaga N, Tokumitsu J, Ikeoka T, Kuriya G, Izumi Y, Kawakami A.

Mod Rheumatol. 2019 Sep 18:1-5. doi: 10.1080/14397595.2019.1666463. [Epub ahead of print]

PMID:
31500483
25.

Late-onset protracted febrile myalgia syndrome successfully treated with colchicine owing to heterozygous MEFV exon 2 variants.

Endo Y, Koga T, Furukawa K, Sumiyoshi R, Ichinose K, Kawakami A.

Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):166. Epub 2019 Jul 22. No abstract available.

26.

Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis.

Matsuoka N, Kozuru H, Koga T, Abiru S, Yamasaki K, Komori A, Fujita Y, Tenmoku J, Asano T, Sato S, Suzuki E, Furuya M, Kobayashi H, Watanabe H, Naganuma A, Yoshizawa K, Shimada M, Ario K, Yamashita H, Kohno H, Kaneyoshi T, Nakamura M, Furukawa H, Takahashi A, Kawakami A, Ohira H, Yatsuhashi H, Migita K.

Medicine (Baltimore). 2019 Aug;98(35):e16924. doi: 10.1097/MD.0000000000016924.

27.

Ultrasound-Proven Severe Synovitis Induced by PD-1 Inhibitor Therapy in a Patient Predisposed to Seronegative Inflammatory Arthritis.

Kawashiri SY, Iwamoto N, Ohba K, Kawakami A.

Case Rep Rheumatol. 2019 Jul 24;2019:7340692. doi: 10.1155/2019/7340692. eCollection 2019.

28.

Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT.

Iwamoto N, Sato S, Sumiyoshi R, Chiba K, Miyamoto N, Arinaga K, Kobayashi M, Yamamoto H, Osaki M, Kawakami A.

Trials. 2019 Aug 13;20(1):494. doi: 10.1186/s13063-019-3589-8.

29.

Anti-citrullinated protein antibody titre as a predictor of abatacept treatment persistence in patients with rheumatoid arthritis: a prospective cohort study in Japan.

Endo Y, Koga T, Kawashiri SY, Morimoto S, Nishino A, Okamoto M, Eguchi M, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Yoshitama T, Eiraku N, Matsuoka N, Okada A, Fujikawa K, Hamada H, Tsuru T, Nagano S, Arinobu Y, Hidaka T, Tada Y, Kawakami A.

Scand J Rheumatol. 2020 Jan;49(1):13-17. doi: 10.1080/03009742.2019.1627411. Epub 2019 Aug 12.

PMID:
31402744
30.

Clinical characteristics of cancer-associated myositis complicated by interstitial lung disease: a large-scale multicentre cohort study.

Kaneko Y, Nunokawa T, Taniguchi Y, Yamaguchi Y, Gono T, Masui K, Kawakami A, Kawaguchi Y, Sato S, Kuwana M; JAMI investigators .

Rheumatology (Oxford). 2020 Jan 1;59(1):112-119. doi: 10.1093/rheumatology/kez238.

PMID:
31382295
31.

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3).

Tanaka Y, Takeuchi T, Tanaka S, Kawakami A, Iwasaki M, Song YW, Chen YH, Wei JC, Lee SH, Rokuda M, Izutsu H, Ushijima S, Kaneko Y, Akazawa R, Shiomi T, Yamada E.

Ann Rheum Dis. 2019 Oct;78(10):1320-1332. doi: 10.1136/annrheumdis-2019-215163. Epub 2019 Jul 26.

32.

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan.

Takeuchi T, Tanaka Y, Tanaka S, Kawakami A, Iwasaki M, Katayama K, Rokuda M, Izutsu H, Ushijima S, Kaneko Y, Shiomi T, Yamada E, van der Heijde D.

Ann Rheum Dis. 2019 Oct;78(10):1305-1319. doi: 10.1136/annrheumdis-2019-215164. Epub 2019 Jul 26.

33.

Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid Arthritis.

Toyama S, Takatani A, Koga T, Eguchi M, Okamoto M, Tsuji S, Endo Y, Shimizu T, Sumiyoshi R, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Furuyama M, Tabuchi M, Kobayashi S, Kanetaka K, Hashisako M, Abe K, Niino D, Sato S, Miyazaki Y, Kawakami A.

Intern Med. 2019 Nov 15;58(22):3331-3336. doi: 10.2169/internalmedicine.2782-19. Epub 2019 Jul 22.

34.

In reply: Flawed analytical method used for reference glucose.

Nakadate Y, Sato H, Roque P, Sato T, Matsukawa T, Wykes L, Kawakami A, Schricker T.

Can J Anaesth. 2020 Jan;67(1):160. doi: 10.1007/s12630-019-01445-1. Epub 2019 Jul 11. No abstract available.

PMID:
31297705
35.

Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder.

Sakaguchi R, Fujikawa K, Okamoto M, Matsuo E, Matsumoto K, Uchida T, Shin-Ya K, Nakashima M, Mizokami A, Kawakami A.

Intern Med. 2019 Nov 1;58(21):3167-3171. doi: 10.2169/internalmedicine.2995-19. Epub 2019 Jul 10.

36.

Versican is crucial for the initiation of cardiovascular lumen development in medaka (Oryzias latipes).

Mittal N, Yoon SH, Enomoto H, Hiroshi M, Shimizu A, Kawakami A, Fujita M, Watanabe H, Fukuda K, Makino S.

Sci Rep. 2019 Jul 1;9(1):9475. doi: 10.1038/s41598-019-45851-3.

37.

Initial human T-cell leukemia virus type 1 infection of the salivary gland epithelial cells requires a biofilm-like structure.

Nakamura H, Shimizu T, Takatani A, Suematsu T, Nakamura T, Kawakami A.

Virus Res. 2019 Aug;269:197643. doi: 10.1016/j.virusres.2019.197643. Epub 2019 Jun 21.

PMID:
31233774
38.

A case of neutrophilic dermatosis with MEFV gene variant and abnormal activation of peripheral blood monocytes: a case report.

Otsuka M, Koga T, Sumiyoshi R, Koike Y, Furukawa K, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Daisuke N, Kawakami A.

Immunol Med. 2019 Mar;42(1):45-49. doi: 10.1080/25785826.2019.1625507. Epub 2019 Jun 16.

PMID:
31204589
39.

Association between human T cell leukemia virus 1 (HTLV-1) infection and advanced periodontitis in relation to hematopoietic activity among elderly participants: a cross-sectional study.

Shimizu Y, Yamanashi H, Kitamura M, Furugen R, Iwasaki T, Fukuda H, Hayashida H, Kawasaki K, Kiyoura K, Kawashiri SY, Saito T, Kawakami A, Maeda T.

Environ Health Prev Med. 2019 Jun 10;24(1):42. doi: 10.1186/s12199-019-0796-6.

40.

Impaired early-phase suppression of glucagon secretion after glucose load is associated with insulin requirement during pregnancy in gestational diabetes.

Horie I, Haraguchi A, Ito A, Nozaki A, Natsuda S, Akazawa S, Mori Y, Ando T, Higashijima A, Hasegawa Y, Yoshida A, Miura K, Masuzaki H, Kawakami A, Abiru N.

J Diabetes Investig. 2020 Jan;11(1):232-240. doi: 10.1111/jdi.13096. Epub 2019 Jul 2.

41.

Lung consolidation and mediastinal lymphadenopathy in patients with early anti-citrullinated protein antibody-positive rheumatoid arthritis.

Endo Y, Koga T, Tsutsui S, Ashizawa K, Kawashiri SY, Kawakami A.

Clin Exp Rheumatol. 2019 May-Jun;37(3):517-518. Epub 2019 Apr 29. No abstract available.

42.

Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis.

Temmoku J, Sato S, Fujita Y, Asano T, Suzuki E, Kanno T, Furuya MY, Matsuoka N, Kobayashi H, Watanabe H, Koga T, Shimizu T, Kawakami A, Migita K.

Medicine (Baltimore). 2019 May;98(20):e15578. doi: 10.1097/MD.0000000000015578.

43.

Removal methods of rigid stylets to minimise adverse force and tracheal tube movement: a mathematical and in-vitro analysis in manikins.

Kotoda M, Oguchi T, Mitsui K, Hishiyama S, Ueda K, Kawakami A, Matsukawa T.

Anaesthesia. 2019 Aug;74(8):1041-1046. doi: 10.1111/anae.14699. Epub 2019 May 15.

PMID:
31093966
44.

Rheumatoid arthritis-like active synovitis with T-cell activation in a case of idiopathic multicentric Castleman disease: A case report.

Otsuka M, Koga T, Sumiyoshi R, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Daisuke N, Kawakami A.

Medicine (Baltimore). 2019 May;98(18):e15237. doi: 10.1097/MD.0000000000015237.

45.

A new heterozygous compound mutation in the CTSA gene in galactosialidosis.

Nakajima H, Ueno M, Adachi K, Nanba E, Narita A, Tsukimoto J, Itoh K, Kawakami A.

Hum Genome Var. 2019 Apr 26;6:22. doi: 10.1038/s41439-019-0054-x. eCollection 2019.

46.

Coexistence of Mixed Connective Tissue Disease and Familial Mediterranean Fever in a Japanese Patient.

Fujita Y, Asano T, Sato S, Furuya MY, Temmoku J, Matsuoka N, Kobayashi H, Watanabe H, Suzuki E, Koga T, Endo Y, Kawakami A, Migita K.

Intern Med. 2019 Aug 1;58(15):2235-2240. doi: 10.2169/internalmedicine.2376-18. Epub 2019 Apr 17.

47.

Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody.

Makita N, Ando T, Sato J, Manaka K, Mitani K, Kikuchi Y, Niwa T, Ootaki M, Takeba Y, Matsumoto N, Kawakami A, Ogawa T, Nangaku M, Iiri T.

JCI Insight. 2019 Apr 18;4(8). pii: 126449. doi: 10.1172/jci.insight.126449. eCollection 2019 Apr 18.

48.

Medication Adherence Among Patients With Chronic Hepatitis Receiving Antiviral Treatment.

Go H, Tanaka M, Yamamoto-Mitani N, Suzuki M, Kawakami A, Masaki N, Shimada M.

Gastroenterol Nurs. 2019 Mar/Apr;42(2):140-149. doi: 10.1097/SGA.0000000000000363.

PMID:
30946301
49.

Clinical features and human T-cell leukemia virus type-1 (HTLV-1) proviral load in HTLV-1-positive patients with rheumatoid arthritis: Baseline data in a single center cohort study.

Eguchi K, Iwanaga M, Terada K, Aramaki T, Tuji Y, Kurushima S, Kojima K, Arima K, Iwamoto N, Ichinose K, Kawakami A, Hirakata N, Ueki Y.

Mod Rheumatol. 2019 Apr 2:1-10. doi: 10.1080/14397595.2019.1602931. [Epub ahead of print]

PMID:
30938551
50.

Familial Mediterranean fever: overview of pathogenesis, clinical features and management.

Migita K, Asano T, Sato S, Koga T, Fujita Y, Kawakami A.

Immunol Med. 2018 Jun;41(2):55-61. doi: 10.1080/13497413.2018.1481579. Epub 2018 Sep 7.

PMID:
30938266

Supplemental Content

Loading ...
Support Center